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ABSTRACT
LINE-1 (L1) is a highly successful autonomous non-
LTR retrotransposon and a major force shaping
mammalian genomes. Although there are about
600000 L1 copies covering 23% of the rat genome,
full-length rat L1s (L1Rn) with intact open reading
frames (ORFs) representing functional master
copies for retrotransposition have not been identi-
fied yet. In conjunction with studies to elucidate the
role of L1 retrotransposons in tumorigenesis, we
isolated and characterized 10 different cDNAs from
transcribed full-length L1Rn elements in rat chloro-
leukemia (RCL) cells, each encoding intact ORF1
proteins (ORF1p). We identified the first functional
L1Rn retrotransposon from this pool of cDNAs,
determined its activity in HeLa cells and in the RCL
cell line the cDNAs originated from and demonstrate
that it is mobilized in the tumor cell line in which it
is expressed. Furthermore, we generated mono-
clonal antibodies directed against L1Rn ORF1 and
ORF2-encoded recombinant proteins, analyzed
the expression of L1-encoded proteins and found
ORF1p predominantly in the nucleus. Our results
support the hypothesis that the reported explosive
amplification of genomic L1Rn sequences after their
transcriptional activation in RCL cells is based on L1
retrotransposition. Therefore, L1 activity might be
one cause for genomic instability observed during
the progression of leukemia.
INTRODUCTION
LINE-1s (Long Interspersed Nuclear Element-1s or L1s)
represent a family of abundant non-long-terminal repeat
(non-LTR) retrotransposons in mammalian genomes.
More than 99.8% of L1s are retrotransposition-defective
because they are 50 truncated, contain internal rearrange-
ments or harbor mutations within their open reading
frames (ORFs) (1–3). However, the average human
genome is estimated to contain 80–100 retrotransposi-
tion-competent (RC) L1s, and  10% of these elements are
classiﬁed as highly active or ‘hot’ (4). By comparison, the
mouse genome is estimated to contain at least 3000 active
L1s (5,6). L1s have shaped mammalian genomes through a
number of mechanisms (7,8). First, they have greatly
expanded the genome both by their own retrotransposition
and by providing the machinery necessary for the retro-
transposition of other mobile elements, such as Alus and
processed pseudogenes. Second, they have shuﬄed non-L1
sequences throughout the genome by a process termed
transduction. Third, they have aﬀected gene expression by
several mechanisms.
The best-studied L1s are those found in mice and men.
There are at least 599000 copies of mouse L1 (L1Md) that
are interspersed in all chromosomes, and together
comprise  19% of the genomic DNA (9). RC L1Mds
are  6500nt in length. Full-length RC-L1s have a 50
untranslated region (UTR) with internal promoter activ-
ity, two ORFs, a 30 UTR that ends in an AATAAA
polyadenylation signal and a poly A tail. The role of the
ORF1-encoded protein (ORF1p) is poorly understood.
ORF1p represents a basic protein that co-fractionates as a
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of human and mouse cells (10–12), binds RNA and single-
stranded (ss) DNA in vitro (13–15), and possesses nucleic
acid chaperone activity (16). It was suggested that ORF1p
is capable of protein–protein interactions (14). The ORF2
protein (ORF2p) provides the enzymatic activities of
endonuclease (EN) (17) and reverse transcriptase (RT)
(18) for a process termed ‘target-site primed reverse
transcription’ (TPRT) (19,20) which is initiating the
insertion of a new non-LTR retrotransposon copy into
genomic DNA. For eﬃcient retrotransposition, both fun-
ctional L1-encoded proteins are required in cis and must be
translated from the primary bicistronic transcript (21).
L1 is the only autonomous non-LTR retrotransposon in
rodents. Approximately 600000 copies, in variable stages
of decay, comprise  23% of the rat genome (22).
Considering the fraction of the genome it is occupying,
L1 of Rattus norvegicus (L1Rn) is the most successful
mammalian L1 retrotransposon identiﬁed so far. Follow-
ing the mouse-rat split, L1 activity appears to have
increased in rat. The 30 UTR sequences deﬁne six rat-
speciﬁc L1 subfamilies, represented by 150000 copies that
cover 12% of the rat genome. L1 copies accumulated over
the same period in mouse cover only 10% of the genome.
This higher accumulation of L1 copies could explain some
of the size diﬀerence between the rat and mouse genome.
Full-length L1Rn elements have a structural arrangement
similar to that of L1Md and many elements are present as
7-kb full-length copies (Figure 1A) (23). The 50 UTR of L1
in rodents is bipartite: there is a 50 module that can occur
as a tandem repeat and therefore is referred to as a
monomer (24) and a 30 module which is called the tether
(25) that links the monomer to ORF1. Although the entire
50 UTRs of the modern mouse and rat L1 subfamilies are
not homologous, the regulatory property of the monomer
was shown using transient expression assays (26). The
50 one-third of murine ORF1s contains a hypervariable
domain (length polymorphic region, LPR), which has
uniquely been the site of repeated deletions and duplica-
tions, and in rat it is the locus of replacement base
substitutions (25,27). The ancestral rat hypervariable
domain contains a 21-bp sequence that is deleted in
some modern L1Rn elements and a 66-bp sequence that is
tandem-duplicated in some elements (28). The currently
active L1 in rat is L1mlvi2 (or L1Rn) (29), but although
evolution of L1Rn elements was intensively studied,
structure and nucleotide sequence of a functional L1Rn
element is unknown hitherto and there is only sparse
information on expression of these elements.
To date, transcriptional activation of L1Rn sequences
by  10-fold was demonstrated in RCL cells reaching
 50% of their maximal population density in suspen-
sion culture (30). Also, UV irradiation was shown to
rapidly induce L1Rn transcription during fast
exponential growth of these cells (31). L1Rn RNA
could be detected in liver, kidney and skeletal muscle
of the adult rat (23), in kidney tissue during the
neonatal period (32) as well as in multipotent neural
progenitor cells and neurons (33). Recently, L1Rn
transcription was shown to be up-regulated in adult
cardiac tissue after ischemia-reperfusion and the presence
of L1-encoded proteins could be demonstrated (34).
Here we describe isolation and characterization of the
ﬁrst functional rat LINE-1 retrotransposon from a pool of
10 diﬀerent cDNAs generated from actively transcribed
endogenous full-length L1Rn elements which are all
coding for intact ORF1ps in rat chloroleukemia (RCL)
cells. We determined the retrotransposition activity of this
active L1Rn element in HeLa cells as well as in the RCL
cell line from which the cDNAs originated. This is the ﬁrst
report on a functional endogenous L1 element that is
mobilized in the tumor cell line in which it was shown to
be endogenously expressed. In order to investigate L1
translation and subcellular localization of L1-encoded
proteins in rat cells, we generated monoclonal antibodies
directed against recombinant ORF1p and ORF2p. Our
experiments revealed that both L1-encoded proteins are
expressed from endogenous elements in RCL cells. While
endogenous ORF1 proteins appeared almost exclusively
in the nucleus, transiently expressed ORF1p localized
predominantly to the cytoplasm. Localization studies with
ORF1p deletion mutants indicate that the N-terminal
third of ORF1p has a function in cytoplasmic retention
and targeting to cytoplasmic intermediate ﬁlaments. Our
data demonstrating expression and retrotransposition of
functional endogenous L1 elements in RCL cells support
the idea that L1 activity might be at least one cause for the
accumulation of molecular and chromosomal abnormal-
ities leading to genomic instability which is characteristic
for the progression of leukemia.
MATERIALS AND METHODS
Cellculture andUV irradiation
RCL cells growing in suspension culture (30) and HeLa
S3 cells were kindly provided by K. Servomaa and by
Dr A. Shatkin, respectively, and maintained in DMEM
containing 10% FCS. Rat embryo ﬁbroblasts (REFs)
and mouse embryo ﬁbroblasts (MEFs) from whole
embryos were cultured in DMEM/10% FCS. Cells were
transfected using FUGENE 6 lipid reagent (Roche). RCL
cells were UV irradiated under following conditions:
312nm (VL-215M; Bioblock Scientiﬁc), 4.65mW/cm
2,a s
measured with a VLH-3W radiometer equipped with a
CX-312 ﬁlter.
Cloning oftranscribed L1Rnsequences from RCL cells
Total and poly(A)
+ RNA were prepared from control and
irradiated RCL cells with the RNeasy and Oligotex
mRNA kits (Qiagen), respectively. cDNA was synthesized
from poly(A)
+ RNA employing SuperScript
TM II reverse
transcriptase (Invitrogen) and oligo(dT) primer. About
6kb long L1Rn sequences encompassing ORF1 and
ORF2 were ampliﬁed from cDNA with the Taq/Pwo
Proof Mix (AGS-Hybaid) and primers Pr-L1Rn1
(50-GGA AGA GAC CAC CAA CAC TGC TCA C-30,
pos. 547 -571) and Pr-L1Rn2 (50-GCT ACA TCC GGC
TCC TGT CAG TCT GC-30, pos. 6600 - 6576) speciﬁc
for the monomeric region of the L1Rn 50 UTR and for
the 30 UTR, respectively (accession no. M13100) (23,35).
Nucleic Acids Research,2008, Vol. 36,No. 2 649The PCR products were cloned into pBluescript II SK (+)
(Stratagene). Ten recombinant plasmids containing L1Rn
cDNA inserts were sequenced.
Northern blot analysis
Two microgram of poly(A)
+ RNA from control
and irradiated RCL cells were separated on standard
formaldehyde-agarose gels, transferred to a nylon mem-
brane (Hybond-N, Amersham Biosciences, Freiburg,
Germany) by vacuum blotting in a Vacu-Blot System
(Biometra, Go ¨ ttingen, Germany), and ﬁxed to the mem-
brane by UV-crosslinking. A 500-bp digoxigenin-labeled
double-stranded (ds) DNA probe speciﬁc for the
EN-coding region of L1Rn (accession no. DQ100480)
was generated by PCR using L1-21 (Figure 1A) as tem-
plate, primers 50-GGT CAG AAA AAG CAA GCT GGA
GTA GCC-30 (pos. 2111–2137) and 50-AGG CCG TGG
TGGTCCGAT AG-30 (pos. 2610–2591),anddigoxigenin-
11-dUTP (Roche) at a molar ratio of 1:20 relative to dTTP.
Hybridization was performedin ULTRAhyb ultrasensitive
hybridization buﬀer (Ambion Europe Ltd.). The chemilu-
minescence-baseddetectionofthedigoxigeninmoietieswas
performed as recommended by the manufacturer (Roche).
Retrotransposition reporter assay
Retrotransposition reporter plasmids pAD5/L1-3 and
pAD6/L1-13 were generated by replacing the 5965-bp
NotI/BstZ17I fragment of pJM101/L1.3 (36), which
encompasses pos. 1-5965 of the human L1.3 element
(37), by the 5860-bp NotI/EcoRV fragments of L1-3 and
L1-13, respectively, comprising the entire particular
cloned L1Rn-cDNA cassette. Antibiotic selection for
transfected HeLa (0.4mg/ml hygromycin) and RCL
(0.7mg/ml hygromycin) cells was started 1 and 3 days
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Figure 1. Full-length L1Rn elements are transcribed in RCL cells. (A) Structure of L1Rn. A functional full-length L1Rn element is characterized by
two ORFs ﬂanked by 50 and 30 UTRs. The bipartite 50 UTR consists of a monomer, which can be tandemly repeated, and a non-repeated tether (t).
The most 50 monomer is only partially duplicated (black truncated box with arrowhead) in all genomic rat elements identiﬁed so far. Horizontal
arrows indicate the binding sites of the oligonucleotides Pr-L1Rn1 and Pr-L1Rn2 used to amplify cDNAs generated from full-length transcripts. The
binding site of the 500-bp digoxigenin-labeled probe used to detect L1-speciﬁc transcripts is localized at the 50 end of ORF2 (black bar). Open bars
represent ORF1- and ORF2-encoded polypeptides against which monoclonal antibodies were raised. The polypeptides are covering amino acid
positions 144–402 and 292–480 of ORF1p and ORF2p, respectively (accession no. DQ100480). LPR, length polymorphism region; GrPPT, G-rich
polypurine tract; An, A-rich 30 tract; EN, endonuclease; RT, reverse transcriptase; C, cysteine-rich motif. (B) L1Rn transcriptional products in RCL
cells. PolyA
+ RNA was isolated from RCL cells that had reached the maximum population density of  10
6 cells/ml (lane 2) and from cells that were
UV-irradiated (lane 1). Two microgram of each RNA were separated by agarose gel electrophoresis and subjected to northern blot analysis using a
500-bp probe (Figure 1A). (C) Schematic structures of 10 L1Rn cDNAs synthesized from poly(A)
+ RNA from UV-irradiated RCL cells. cDNAs are
ﬂanked by primer sequences Pr-L1Rn1 and Pr-L1Rn2. Names of the resulting cDNAs are listed on the left, while accession numbers are speciﬁed on
the right. Termination codons within ORF2 sequences are indicated by vertical arrows. Two deletions in the ORF2-coding region of cDNA L1-17
covering 103 and 220 nts, respectively, are indicated by interrupted bars.
650 Nucleic Acids Research, 2008, Vol. 36, No. 2after transfection with FUGENE 6 lipid reagent, respec-
tively. HeLa cells were selected for hygromycin resistance
for 14 days, followed by G418 (1mg/ml) selection for 11
days. Resulting colonies were stained with Giemsa
solution. RCL cells growing in suspension were selected
for hygromycin resistance for 29 days, followed by G418
(1.5mg/ml) selection for at most 27 days. G418
R RCL
suspension cells were maintained and passaged in DMEM
containing 10% FCS and 1.5mg/ml G418. Live cell
imaging was performed by trypan blue exclusion.
30-junctions of L1-3 de novo retrotransposition events
from the large background of HeLa genomic DNA were
identiﬁed by EPTS/LM PCR (38) (Supplementary Data,
Experimental Procedures).
Protein expression and purification
For expression of recombinant L1Rn ORF1p in Escher-
ichia coli, the pET System (Merck Biosciences GmbH) was
employed (Figure S6, A to C). Recombinant, 6xHis-tagged
ORF1p, ORF1p
1–143, and ORF2p
M292–480 were puriﬁed
from soluble protein fractions and inclusion bodies via the
cobalt IMAC resin Talon (BD Biosciences) technique,
using gravity ﬂow columns under native and denaturing
conditions, as described in the user manual. Full-length
recombinant Trx-6xHis-ORF1p
1–143, ORF1p
1–143
-6xHis and ORF1p-6xHis, devoid of C- and N-terminal
degradation products, were obtained by ssDNA-cellulose
[heat-denatured calf thymus DNA (Sigma, Deisenhofen,
Germany) covalently bound to CF-11 cellulose (Whatman,
Go ¨ ttingen, Germany)] chromatography. Brieﬂy, to
exchange buﬀer, protein samples were dialyzed against
ssDNA-cellulose binding buﬀer (10mM Tris–HCl, pH 7.6,
10mM EDTA, 6mM 2-mercaptoethanol, 6M urea) and
applied to a small column packed with ssDNA-cellulose.
Bound protein was eluted with a 0–200mM KCl gradient
in binding buﬀer. The full-length products were detected in
the fractions eluted at 150mM KCl.
SDS–polyacrylamide gelelectrophoresis and electroelution
Standard SDS–PAGE was carried out in Mini-Protean II
dual slab cells (Bio-Rad, Munich, Germany). The
separated proteins were stained with Coomassie brilliant
blue or visualized by silver staining with the GelCode
SilverSNAP stain kit (Perbio Science, Bonn, Germany).
After preparative 9–15% gradient SDS–PAGE followed
by copper staining, the desired protein bands were excised
and electroeluted using the Model 422 Electro-Eluter
(Bio-Rad), employing conditions recommended by the
manufacturer.
Anti-ORF1p and -ORF2pmouse monoclonal antibodies
Recombinant Trx-6xHis-ORF1p
1–143 and -ORF2p
M292–
480 fusion proteins were expressed from pET32b-
ORF1
1–143 and pET32b-ORF2
M292–480 (Figure S6, A
and F; Supplementary Data, Experimental Procedures),
respectively, puriﬁed by electroelution from preparative
SDS–polyacrylamide gradient gels and used for the
immunization of BALB/c mice. Immunization and pre-
paration of hybridoma cells were carried out as described
in standard protocols. Myeloma P3X63-Ag8.653 cells
were kindly provided by G. Ha ¨ mmerling (DKFZ,
Heidelberg, Germany) and maintained in RPMI-1640
(ICN Pharmaceuticals) supplemented with 15% FCS. For
antibody production, hybridoma cells were grown in
serum-free RPMI medium plus 10% HC-3 supplement,
formulated on the basis of colostrum ultraﬁltrate
(BioConcept, Umkirch, Germany). Primary analysis and
screening of hybridoma cells were performed employing
the immuno-dot-blotting method. For that purpose, the
tagged L1-encoded antigens used for immunization were
immobilized on a nitrocellulose membrane (0.45mm;
Schleicher & Schuell, Dassel, Germany), which was ﬁxed
in a 96-well dot blot chamber (‘Minifold’, Schleicher &
Schuell). To exclude hybridoma clones producing anti-
bodies against Trx- and/or 6xHis tags, all selected clones
in the primary analysis were then tested using total cell
lysate of bacteria expressing the Trx-6xHis fusion protein
from pET32b(+) (Novagen). Mice immunized with Trx-
6xHis-ORF1p
1–143 and -ORF2p
M292–480 fusion proteins
were used to obtain hybridoma clones referred to as rG24
(isotype IgG2, k light chain) and 2H9 (isotype IgM, k light
chain), respectively. The speciﬁcity of the monoclonal
antibodies was further tested by immunoﬂuorescence
staining of transfected cells, immunoprecipitation, immu-
noblotting and/or mass spectrometry. Antibodies from
supernatants of the hybridoma cells were used either
directly or, depending on isotype, puriﬁed by aﬃnity
chromatography on protein G-Sepharose (Amersham
Biosciences) or protein L-agarose (Perbio Science).
Indirect immunofluorescence
Adherent (REF and Hela) and suspension (RCL) cells
were plated in a 6-well culture plate on untreated or poly-
L-lysine (Sigma)-coated glass coverslips, respectively, at a
density of 5 10
4cells/well, ﬁxed with 4% paraformalde-
hyde in PBS and permeabilized with 1% Triton X-100 in
PBS. Immunostaining of cells was done as previously
described (39). For in situ protein overlay, MEF cells were
ﬁxed with 4% paraformaldehyde in 1 PBS and permea-
bilized with 1% Triton X-100 in 1 PBS [as described for
conventional immunostaining (39)], incubated in 1 PBS
(pH 7.4) containing 1% bovine serum albumin (BSA) for
30min, treated with a solution of recombinant ORF1p
(50mg/ml in 1% BSA/PBS, pH 7.4) for 30min, washed
three times with PBS (pH 7.4) and treated with 4%
paraformaldehyde for 10min. After washing and blocking
in 1% BSA/PBS, cells were stained with anti-ORF1p
(rG24) and aﬃnity-puriﬁed polyclonal goat anti-vimentin
antibodies (39). The cell specimens were examined on a
Leica TCS SP2 confocal laser scanning microscope
(CLSM) equipped with argon/krypton and neon ion
lasers (Leica Lasertechnik, Heidelberg, Germany). In the
case of double/triple labeling, the sequential mode of
scanning was employed, capturing the images separately
for each ﬂuorescent dye used. To improve the signal-
to-noise ratio, eight scans of one focal plane were
averaged. Following image acquisition, the raw data
were exported to the Huygens Essential software (version
2.7.2p0, Scientiﬁc Volume Imaging B.V., Hilversum,
Nucleic Acids Research,2008, Vol. 36,No. 2 651The Netherlands; http://www.svi.nl) and digital deconvo-
lution was performed using the Maximum Likelihood
Estimation (MLE) algorithm. The restored image data set
was visualized and processed with the Imaris software
package (version 4.1.3, Bitplane AG, Zu ¨ rich, Switzerland;
http://www.bitplane.com). Co-localization was analyzed
with the ImarisColoc module integrated into the Imaris
software package and the map of the co-localized voxels
was saved as separate channel.
Immunoprecipitation ofORF1p and ORF2p
10
8 RCL cells were treated with 1ml of lysis buﬀer
(1% Triton X-100, 20mM Tris–HCl, pH 8.0, 150mM
NaCl, 1mM EDTA) supplemented with Protease
Inhibitor Cocktail Set III and brieﬂy sonicated on ice.
After pre-absorption with protein G-Sepharose or protein
L-agarose (Pierce) for 1h at 48C, the cell lysate was
supplemented with monoclonal anti-ORF1p (rG24) or
anti-ORF2p (2H9) antibody at a ratio of 1mg of antibody/
100mg of cellular protein, and gently shaken for 10–12h at
48C. Subsequently, 50ml (packed bed volume) of protein
G-Sepharose or protein L-agarose in lysis buﬀer were
added and the suspension was incubated for another 4h at
48C. The matrix-bound immunocomplexes were pelleted
by centrifugation and washed with lysis buﬀer ﬁve times
for 10min, before the immunocomplexes were eluted with
SDS–PAGE sample buﬀer lacking 2-mercaptoethanol and
analyzed by SDS–PAGE and silver staining.
Subcellular fractionation
Subcellular fractionation was performed using the
ProteoExtract, Subcellular Proteome Extraction Kit
(Calbiochem, Nottingham, UK). Protein fractions were
enriched by acetone precipitation to use them for
immunoblot analysis. Lamin B was used as a marker for
nuclear and cytoskeletal matrix fractions.
Immunoblot analyses
RCL cell extracts and puriﬁed proteins were separated on
SDS–polyacrylamide gels and electroblotted onto nitro-
cellulose membranes (Schleicher & Schuell). After protein
transfer, membranes were blocked for 1h in a 10%
solution of non-fat milk powder in Tris-buﬀered saline
(TBS, 10mM Tris–HCl, pH7.6, 150mM NaCl), and
incubated with the respective primary antibody overnight
at 48C. To detect L1Rn-ORF2p, monoclonal 2H9 anti-
body was used in a 1:20 dilution in TBS/0.1% Tween 20
containing 1% milk powder, membranes were washed
four times with TBS/0.1% Tween 20 and incubated with
an HRP-conjugated, secondary anti-mouse IgM antibody
(Dianova) at a dilution of 1:10000 for 45min. To detect
L1Rn-ORF1p, primary monoclonal rG24 antibody was
used at a dilution of 1:20, whereas the HRP-conjugated
secondary anti-mouse IgG antibody was applied at
dilutions of 1:10000. After incubation with the secondary
antibody, membranes were washed four times with TBS/
0.1% Tween 20 and immunocomplexes were visualized
using luminol-based ECL western blotting reagent
(Amersham Biosciences). Anti-His Tag antibody G-18
(Santa Cruz Biotechnology), monoclonal anti-b-actin
antibody (Sigma), and anti-a1-catenin antibody (Abcam)
were used according to manufacturer’s protocols. Digital
gel images were captured with a Bio-Rad Fluor-S
MultiImager and processed with Bio-Rad Quantity One
Software (Bio-Rad) and Adobe Photoshop CS2 software
(Adobe Systems Inc., Mountain View, CA, USA).
Dot blot overlay assay
Puriﬁed L1Rn-ORF1p was diluted in 1 PBS, pH7.4 at
0.66mg/ml and applied onto a nitrocellulose membrane
using a dot blot ﬁltration apparatus (2mg/dot). Protein
samples were allowed to adsorb onto the membrane for
30min before vacuum ﬁltration. The membrane was
incubated in blocking buﬀer (5% non-fat dry milk/
1 TBS) for 30min. The nitrocellulose membrane was
cut into four squares each carrying one ORF1p dot.
Subsequently, each membrane square was incubated in
2ml blocking buﬀer supplemented with 5mg/ml of puriﬁed
vimentin, a-tubulin or b-actin, respectively. Cytoskeletal
proteins bound to immobilized-ORF1p were detected
employing primary antibodies speciﬁcally directed against
each of the diﬀerent cytoskeletal proteins and luminol-
based ECL western blotting reagent. Antibodies used
were goat anti-vimentin (39), mouse anti-b-actin/clone
AC-40 (Sigma) and rat anti-a-tubulin/clone YOL 1/34
(Chemicon). Respective secondary antibodies were pur-
chased from Santa Cruz Biotechnology. Recombinant
mouse vimentin was produced in E. coli. Bovine a-tubulin
and human b-actin were purchased from Cytoskeleton,
Inc. (Denver, CO, USA).
In-silico analyses
Potential coiled-coil sequences in ORF1ps were searched
for by accessing the MARCOIL server [http://www.
isrec.isb-sib.ch/webmarcoil/webmarcoilC1.html; (40)].
Sequence alignments were calculated using the Clustal X
(1.83) program (41). BLAST analysis of L1Rn sequences
was performed using the L1base web portal [http://
l1base.molgen.mpg.de/; (42)]. The collection of 377
L1Rn entries from this database was kindly provided by
Tomasz Zemojtel (Max-Planck-Institute for Molecular
Genetics, Berlin, Germany). Nuclear localization signals
were predicted employing the WoLF PSORT (Protein
Subcellular Localization Prediction) program [http://
wolfpsort.seq.cbrc.jp; (43)] and PredictNLS server
[http://www.rostlab.org/predictNLS/; (44)].
RESULTS
Isolation of cDNAs generatedfrom polyadenylated
full-length L1RnRNAs
In order to identify functional L1Rn elements and
characterize their expression, we were seeking for cell
lines and/or growth conditions which are distinguished by
an activation of L1Rn transcription. We chose RCL cells,
since they were reported to increase transcription of
endogenous L1s by  10-fold after they reached 50% of
the maximum population density of the suspension
culture, and by even more as a consequence of UV
652 Nucleic Acids Research, 2008, Vol. 36, No. 2irradiation (30,31). Polyadenylated [poly(A)
+] RNA was
prepared from RCL cells that were growing under the
aforementioned conditions activating L1 transcription,
and submitted to northern blot analysis using a probe
speciﬁc for the EN-coding region of L1 ORF2 (Figure 1A
and B). Among the three detected transcriptional
products, a predominant  7-kb band corresponds to
full-length L1Rn transcripts. The probe also detected
high-molecular-weight transcripts that migrated at 8.3 and
 4.7-kb. The 8.3-kb transcript could be the consequence
of transcriptional read-through of a full-length L1
element, while the latter might result either from
transcription of distinct 50-truncated L1Rn copies or
from premature polyadenylation which has been shown
to be conserved in mammalian L1s (45).
To identify and isolate full-length RC-L1s from rat,
cDNA derived from RNA of UV- irradiated RCL cells
was used as template for long-distance PCR employing
the oligonucleotides Pr-L1Rn1 and Pr-L1Rn2 which are
speciﬁc for the monomeric promoter region of the 50 UTR
(35) and for the 30 UTR of L1Rn, respectively (Figure 1A).
Ten resulting PCR products were cloned and sequenced
(Figures 1C and S1), each consisting of  5.9kb L1Rn
sequences ﬂanked by  640nt 50 UTR- and  260nt 30 UTR
sequences. As a consequence of the chosen 50 UTR-speciﬁc
oligonucleotide Pr-L1Rn1, which binds position 156–181
of the functional L1Rn promoter region (26,35), the
ampliﬁed 50-UTR sequences are covering only the follow-
ing 450–453bp of the 608-bp promoter sequence
(Figure S1). Although the most prominent sequence
divergences were observed in the highly heterogeneous
N-terminal third of ORF1p (Figures 2A and S2A), none of
the 10 cloned L1Rn cDNA sequences carried any
termination codon within ORF1. In contrast, only two
isolated cDNAs, L1-3 and L1-13, represent typical
mammalian L1-specifc bicistronic RNAs and are char-
acterized by potentially functional ORF2p coding regions
that are not interrupted by any termination codons,
  Name    ORF1 class sequence alignment  
  L1mlvi-rn14   I-21pmod-type   1 --------------MARGKRRNPSNRNQDYMPSSEPNSPTKTNMEYPNTPEKQDLVSKSYLIMMLEDFKKDM-NTLREAQENINK---------------- 
  L1-3   I-21pmod-type   1 --------------margkrrnpsnrnqdcmpssepnspaktnmeypntpekqdlvsksylimmledfkkdm-ntlretqeiink---------------- 
  L1-8   I-21pmod-type   1 --------------margkrrnpsnrnqdympssepnsptktnmeysntpekqdlvsksylimmpedfkkdm-ntlretqenink---------------- 
  L1-10   I-21pmod-type   1 --------------margkrrnpsnrnqdympslepnsptktnmeypntpekqdlvsksylimmledfkkdm-ntlretqenink---------------- 
  L1-12   I-21pmod-type   1 --------------margkrrnpsnrnqdympssepnsptktnmeypntpekqdlvsksylimmledfkkdm-ntlreaqenink---------------- 
  L1-13   I-21pmod-type   1 --------------margkrrnpsnrnqdympssepnsptktnmeysntpekqdlvsksylimmledfkkdm-ntlretqenink---------------- 
  L1-23   I-21pmod-type   1 --------------margkrrnpsnrnqdcmpssepnsptktnmeypntpekqdlvsksylimmledfkkdm-ntlretqeiink---------------- 
  L1-17   I-21aanc-type   1 --------------margkrrnpsnrnqdymapsepnspiktnmeypntpekqdlvsksflimmledfkkdvknslre-------qveayrees------- 
  L1-19   I-21aanc-type   1 --------------margkrrnpsnrnqdymassepnsptkanteypntlenqdlvsksylimmledvkkdvknslre-------qveayrqes------- 
  L1-21   I-21aanc-type   1 --------------margkrrnpsnrnqdymapsepnspiktnmdipntpekqdlfsksylimmledfkkdmknslre-------qveayreesqkclkes 
  L1-22   I-21aanc-type   1 mseiaeqsntrdnlmvrgkrrkpsnrnqdymapsepnspiktkkeypntpekqdlvsksflimmledfkkdiknshre----------------------- 
 
  L1mlvi-rn14   I-21pmod-type     -----------------------------------QVKAYREESQKSLKEFQENTIKQLKELKMEIEAIKKEHMETTLDI(115)………………………?? 
  L1-3   I-21pmod-type     -----------------------------------qveayreewqkslkefqentikqmkelkmeieaikkehmettldi(115)………………………rn 357 
  L1-8   I-21pmod-type     -----------------------------------qveayreesqkslkefqentikqlkelkmeieaikkehmettldi(115)………………………rn 357 
  L1-10   I-21pmod-type     -----------------------------------qveayreesqkslkefqentikqlkelkmeieaikkehmettldi(115)………………………rn 357 
  L1-12   I-21pmod-type     -----------------------------------qvkayreesqkslkefqentikqlkelkmeieaikkehmettldi(115)………………………rn 357 
  L1-13   I-21pmod-type     -----------------------------------qveayreesqkslkefqentikqlkelkmeieaikkehmettldi(115)………………………rn 357 
  L1-23   I-21pmod-type     -----------------------------------qveayreewqkslkefqentikqmkelkmeieaikkehmettldi(115)………………………rn 357 
  L1-17   I-21aanc-type     qkclkefqeninkqveahreetqkplkefqeninkqveahreetqkslkefqentikqlkelkmeieaikkehmettldi(153)………………………rn 395 
  L1-19   I-21aanc-type     qkslkefkeiinkqveahreesqksqkefqeiintkveahrevsqkslkefqentikqlkelkmeieaikkehmettldi(153)………………………rn 395 
  L1-21   I-21aanc-type     qkslkefqeninkqveahreetqkslkefqeninkqveahreetqkslkefqentikqlkelkmeiepikkehmettldi(160)………………………rn 402 
  L1-22   I-21aanc-type     -----------------------------------qveayreesqkslkecqentikqlkelkmeieaikkehmettldi(123)………………………rn 365
*
---------------------------IGR---------------------------------
L1Md    ACAAGAAGGTAATCCCTCAACAAACCTAAAAGAAGACAGCCACAAGAACAGA-----------------------ATGCCACCT
T  R  R                                                 M  P  P
L1Rn    GCAAGAAACTAATCGTCTTGGCAACAAAAAAAAAGAGAATGAAAGCACACAAACATAACCTCACATCCAAAT---ATGAATATA
A  R  N                                                 M  N  I
L1Hs    GCCAAAATGTAAAGACCATCGAGACTAGGAAGAAACTGCATCAACTAATGAGCAAAATCACCAGCTAACATCATAATGACAGGA
A  K  M                                                 M  T  G
ORF1
A
B ORF2
Figure 2. Analyses of cDNA-encoded ORF1p classes and intergenic regions (IGR). (A) Alignment of the N-terminal third of the cDNA-encoded
ORF1p sequences including the hypervariable region. Amino acid substitutions and insertions relative to the L1mlvi2-rn14 reference sequence (accession
no. U87602) are in bold and underlined. Lysine deletion at position 59 (asterisk) and a seven-amino acids insertion (black bar) are hallmarks
diagnostic for the I-21pmod-type class. Twenty-two-amino acids tandem repetitions are indicated by arrows. cDNA names and ORF1 classes to which
the encoded protein sequences can be allocated, are listed. (B) Alignment of the non-coding IGR of the functional L1Rn-cDNA L1-3 with IGRs of
functional L1Md (accession no. AY053455) and L1Hs (accession no. M80343) elements. The sequences start in the poorly conserved C-terminal
regions of ORF1 and extend through the ﬁrst ATG of ORF2. ORF1 stop codons as well as stop codons that are localized in the IGRs and are in
frame with ORF1 are underlined; ATG start codons of each ORF2 are italicized.
Nucleic Acids Research,2008, Vol. 36,No. 2 653insertions and/or deletions (Figures 1C and S3). Based on
the nomenclature of the heterogeneous ORF1 regions
(25,29), we categorized our L1Rn sequences in the two
classes I-21p and I-21a characterized by the presence (p) or
absence (a) of a seven-amino acids insertion around
position 64. Figure 2A shows an alignment of amino acid
sequences of the hypervariable N-terminal third (N-1/3)
of ORF1 proteins encoded by the cloned L1Rn cDNAs
with the ORF1p sequence of L1mlvi2–rn14 (accession no.
U87602), which is a member of the currently active L1
family in R. norvegicus (29). ORF1p sequences encoded by
L1-3, -8, -10, -12, -13 and -23 are of the I-21pmod-type class,
deﬁning the modern, most recently emerged subfamily
of L1Rn-encoded ORF1ps (25). Members of this family
have the characteristic lysine deletion at position 59 and
a 7-amino acid insertion in the N-1/3 region of ORF1p.
Both deletion and insertion are absent in ORF1ps encoded
by L1-17, -19, -21 and -22 (Figure 2A). L1-17-, -19- and -
21-encoded ORF1ps include tandem repeats in the
hypervariable N-terminal region. While L1-17 and -19
are coding for proteins carrying two slightly diﬀering 22-
amino acid tandem repeat insertions resulting from non-
synonymous base substitutions, L1-21 is coding for a
protein characterized by a 7-amino acid imperfect duplica-
tion in the ﬁrst tandem repeat (Figure 2A). In sharp
contrast to these I-21a class sequences, L1-22 is encoding
an ORF1p lacking tandem repeats. L1-22 apparently has
the potential for an alternative translational start site at
nucleotide position -42, leading to an extension of ORF1p
at its N-terminus by 14 amino acids (Figures 2A and S2A).
Only 2 out of the 10 isolated L1Rn cDNA sequences,
L1-3 and L1-13 (Figure 1C), have an intact ORF2 with
coding capacity for a  150kDa protein (1275 amino
acids) including an N-terminal EN domain (residues
1–239), a central RT domain (residue 509–774) and a
C-terminal zinc knuckle-like domain with a CX3CX7HC
zinc-binding motif (residue 1131–1144). All three domains
are highly conserved in mammalian L1-encoded ORF2
proteins (Figures 1A and S3). ORF2 regions of L1-8 and
L1-23 are each disrupted by a termination codon (L1-8:
481CAG! TAG; L1-23:
1372GAA! TAA; Figures 1C
and S3). The remaining six ORF2 sequences are char-
acterized by termination codons and deletions (Figure 1C;
accession numbers: DQ100476–DQ100481) [Nucleotide
sequences of the L1Rn-speciﬁc cDNAs were deposited in
the NCBI nucleotide database (GenBank accession
numbers: DQ100473–DQ100482)]. The most prominent
deletions covering 103 and 220bp are found in the ORF2
region of L1-17 (Figures 1C and S1).
The intergenic non-coding spacer regions (IGR)
between ORF1 and ORF2 of the diﬀerent L1Rn cDNAs
have lengths varying from 58 to 60nt and are 99%
identical to each other (Figures 1A, C and S5). The spacer
sequences are rich in adenines and bear resemblance to
those from active mouse and human L1s (Figures 2B and
S5). In the case of the intact L1-3 cDNA, the 60-base
inter-ORF spacer contains two in-frame stop codons and
separates both intact L1 ORFs from each other.
Taken together, our data show that in RCL cells a
multitude of diﬀerent full-length L1Rn copies are actively
transcribed and the resulting RNAs are polyadenylated.
While each identiﬁed cDNA encodes an intact ORF1p,
only two cDNAs, L1-3 and L1-13, are coding for intact
and more conserved ORF2 proteins and could have the
potential to actively retrotranspose.
The L1-3 cDNA is retrotransposition-competent
in cultured cells
We next determined whether the non-interrupted ORFs in
L1-3 and L1-13 encode functional proteins, which are able
to facilitate L1 retrotransposition. For that purpose, we
used a cell culture assay that accurately detects authentic
retrotransposition events (46,47). In this assay, L1 retro-
transposition does not require an intact 50 UTR if an
exogenous promoter is provided. We replaced the human
L1.3 sequence of pJM101/L1.3 covering the 50UTR, both
ORFs and the 50 part of the 30UTR (37) by the L1-3
and L1-13 cDNA sequences (Figure 1C) which are lack-
ing 155nt of the 50 end of the L1Rn-speciﬁc promoter
sequence (35). In the resulting retrotransposition reporter
constructs, pAD5/L1-3 and pAD6/L1-13 (Figure 3A),
transcription of the L1Rn cDNAs was under control of
the cytomegalovirus (CMV) immediate early promoter.
While the control construct pJM101/L1RP (48) as well
as pAD5/L1-3 generated G418
R foci in HeLa cells, both
the EN-defective L1RP-mutant expressed by pJM101/
L1RPH230A and pAD6/L1-13 failed to generate G418
R
foci (Figure 3B). pAD5/L1-3 generated retrotransposition
events at frequencies of 30% relative to pJM101/L1RP,
while pAD6/L1-13 did not retrotranspose at all
(Figure 3B, Table 1). As both ORFs encoded by L1-13
are not destroyed by stop-codons or deletions, we
conclude that single point mutations within the ORFs
might have inactivated the retrotransposition capacity of
the L1-13 element. cDNA sequences of the active L1-3
and the inactive L1-13 element vary in 9, 2 and 5
nucleotides in their 50-UTR-, IGR and 30-UTR sequences,
respectively. Point mutations within the coding regions are
resulting in 6 and 20 amino acid substitutions in ORF1p
and ORF2p, respectively (Figures S2A and S3). However,
the three blocks of amino acids, REKG (pos. 257–260),
ARR (pos. 282–284) and YPAKLS (pos. 304–309), which
are essential for L1 retrotransposition (46), localized close
to the C-terminal end of L1-ORF1p and are highly con-
served among rat, mouse, rabbit and human are also
conserved between L1-3 and L1-13.
Next, we examined the genomic structures generated by
retrotransposition events that derived from the active L1-3
element. Analysis of pre- and post-integration sites of
three pAD5/L1-3-derived insertions isolated from HeLa
cells (Figure 3C) revealed structural hallmarks of mam-
malian L1 retrotransposition, like 50 truncations, target
site duplications (TSDs), poly(A)
+ tails at their 30 ends, a
50-TTTT/A-30 consensus target sequence and, in one case,
the insertion of ﬁve extra nucleotides between TSD and
50-end of the L1 sequence (49,50). Taken together,
structures of the post-integration sites indicate that they
result from conventional TPRT as described for human
L1 retrotransposition (19).
To determine whether the RC L1-3 cDNA is also able to
retrotranspose in RCL cells the RNA was isolated from,
654 Nucleic Acids Research, 2008, Vol. 36, No. 2cells were transfected separately and in triplicate with the
L1Rn reporter constructs (pAD5/L1-3, pAD6/L1-13), and
with the control constructs (pJM101/L1RPH230A,
pJM101/L1RP) and selected for de novo retrotransposition
by growth in G418-containing medium for up to 27 days
(Figure 4A). Whereas RCL cells transfected with the
negative control constructs pJM101/L1RPH230A and
pAD6/L1-13 were completely eliminated after 25 days
of G418-selection, G418
R cells did arise after transfec-
tion with the active L1 constructs pAD5/L1-3 and
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Figure 3. The L1Rn element L1-3 retrotransposes at high frequency in HeLa cells. (A) L1Rn retrotransposition reporter constructs. The human L1.3
sequence of pJM101/L1.3 (ﬂanked by NotI and BstZ17I sites) was replaced by the L1-3 and L1-13 cDNAs (ﬂanked by NotI and EcoRV sites),
respectively. The resulting reporter constructs are pAD5/L1-3 and pAD6/L1-13. (B) Results of the retrotransposition reporter assay. G418
R foci were
ﬁxed to 6-well dishes and stained with Giemsa solution. At the timepoint of transfection with pAD5/L1-3 (well # 2, 3, 5, 6), pAD6/L1-13 (well # 8, 9)
and the control constructs pJM101/L1RP (+C, well # 4, 7) and pJM101/L1RPH230A (–C, well # 1), respectively, each well was containing 2 10
5
HeLa cells. The negative control construct pJM101/L1RPH230A is expressing an EN-defective allele of L1RP.( C) Structures of three L1-3-derived
genomic de novo insertions. Both post-integration sites and pre-integration sequences are shown. The nucleotide position of the 50 truncation within
the L1 reporter cassette is indicated. Numbering corresponds to the nucleotide position in the active L1-3 element (accession no. DQ100473).
Insertion lengths range from 1.47 to 4.01kb. All insertions are demonstrating the structural hallmarks of retrotransposition by TPRT as they are
truncated at their 50 ends, end in a poly(A)
+ tail, and are ﬂanked by short TSDs (red) of 3–15bp. All three insertions integrated into sequences (blue)
that are preferred sites for mammalian L1 integration in vivo (as denoted by the vertical arrows). The L1 endonuclease cleavage site on the bottom
strand is indicated in blue. Notably, insertion #1 is truncated 15 nucleotides upstream of the 30 end of the mneoI indicator cassette (pos. 5976). This
insertion also resulted in ﬁve extra nucleotides (indicated in green) at the left junction between L1-mneo and genomic DNA.
Nucleic Acids Research,2008, Vol. 36,No. 2 655pJM101/L1RP and grew to a maximum density of
1.3–1.5 10
6cells/ml (Figure 4A). To test whether the
G418
R RCL suspension cultures that were derived from
pAD5/L1-3- and pJM101/L1RP-transfected cells, are still
able to proliferate, growth curves of each of the six
diﬀerent cultures were determined (Figure 4B). The
observed exponential growth of the six G418
R RCL
cultures to a maximum density of  1.5 10
6 cells/ml is
consistent with stable integration of intact neo
R genes in
each of the cultures.
To verify that the observed G418 resistance of pAD5/
L1-3- and pJM101/L1RP- transfected RCL cells is a
consequence of retrotransposition events launched from
these plasmids, genomic DNA was extracted from G418
R
RCL cells after 28 days of G418 selection. Using the
genomic DNAs as templates, PCR was performed
employing neo
R gene-speciﬁc primers ﬂanking the intron
in the neo
R gene to determine whether the intron was
spliced from the retrotransposition indicator cassette.
The presence of an 870-bp PCR product ampliﬁed from
genomic DNA, which was isolated from pAD5/L1-3- and
pJM101/L1RP -transfected cells (Figure 4C) clearly
indicates that the spliced functional neo
R cassette was
retrotransposed together with the respective L1 element.
The presence of an additional 1773-bp PCR product in the
case of pJM101/L1RP -transfected cells, which is indicative
for the unspliced neo
R cassette, is suggesting that the
reporter plasmid either integrated into the genome or is
still present episomally. Taken together, the data demon-
strate authentic retrotransposition from pAD5/L1-3 and
pJM101/L1RP in RCL cells. These results are also
indicating that the functional genomic L1-3 element the
isolated cDNA is derived from is actively retrotransposing
in the RCL tumor cell line as well.
The L1Rn cDNAs we had identiﬁed could not be
attributed unambiguously to deﬁned L1 copies annotated Days after transfection
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Figure 4. Functional L1Rn elements retrotranspose in RCL suspension
cells. (A) Growth curves of diﬀerently transfected RCL cells. Cells were
transfected with pJM101/L1RP, pJM101/L1RPH230A, pAD5/L1-3 and
pAD6/L1-13, separately, and were grown in hygromycin-containing
medium for the following 29 days. Transfection experiments were
performed in triplicate. In each of these experiments identical numbers
of hygromycin-resistant cells (Hyg
R) expressing the diﬀerent L1
retrotransposition reporter constructs were then plated in medium
containing G418 separately, and selected for G418 resistance for
another 28 days. Live cells were counted by trypan blue exclusion.
Transfection of RCL cells with pAD6/L1-13 or with the negative
control construct pJM101/L1RPH230A led to the elimination of RCL
cells after 18-25 days of G418 selection. By contrast, transfection with
pJM101/L1RP and pAD5/L1-3 was leading to G418
R cells that
continued to grow at a density of 1.3–1.5 10
6 cells/ml. Each curve
represents arithmetic means of cell densities resulting from three
independent transfection experiments performed with the same reporter
plasmid. Error bars were calculated but are barely visible because the
courses of each of the three growth curves are almost identical.
(B) When cell densities of pJM101/L1RP- and pAD5/L1-3-transfected
suspension cultures reached their maximum after 26–30 days of G418
selection in all six independent transfection experiments, neo
R-cells of
each suspension culture were harvested to inoculate G418-containing
medium at a density of 2 10
3 cells/ml in order to monitor growth
curves of the diﬀerently transfected RCL cells. Rapid exponential
growth without cell loss is demonstrating proliferation of pJM101/
L1RP- and pAD5/L1-3-transfected and neo
R-selected RCL cells in all
three independent experiments. Error bars were calculated but are not
visible as the courses of all six growth curves are almost identical.
(C) PCR assay for correct splicing of the artiﬁcial intron in the neo
R
gene after retrotransposition from the reporter plasmids pJM101/L1RP
and pAD5/L1-3. Genomic DNA was extracted from the diﬀerentially
transfected RCL cells after 28 days of G418 selection, and used as
template for PCR (lanes 3 and 4). This strategy allows distinction of
the spliced and reverse-transcribed form of the neo
R gene (870bp PCR
product) from the original unspliced form (1773bp PCR product)
expressed from the reporter construct and conﬁrmed integration
into the genome via authentic retrotransposition (80,81). PCR was
performed on pAD5/L1-3 plasmid DNA mixed with genomic RCL
DNA (lane 1), pSV2neo (BD Biosciences) mixed with genomic RCL
DNA (lane 2), genomic DNA from pJM101/L1RP–transfected
RCL cells (lane 3), and genomic DNA from pAD5/L1-3 –transfected
RCL cells (lane 4); lanes 5 and 6, negative control genomic DNAs from
untransfected RCL and HeLa cells, respectively; lane 7, minus template
control; lane M, 1-kb Plus DNA ladder (Invitrogen).
Table 1. Retrotransposition frequencies of tested L1 reporter constructs
Construct N Retrotransposition
frequency
( 10
 6)
Experimental
range
( 10
 6)
Wild-type
activity
(%)
pJM101/L1RP 3 2837 2470–3090 100
pAD/L1-3 8 853 690–1000 30.1
pAD/L1-13 8 0 0 0
pJM101/L1RPH230A 3 1.3 0–4 0.05
N=number of individual transfection experiments.
656 Nucleic Acids Research, 2008, Vol. 36, No. 2in the present R. norvegicus genome database. This is not
really surprising as it is known that only 50–60% of
functional L1 sequences are ﬁxed in mammalian genomes
(4,51,52). This means that our particular active L1-3
sequence might not be annotated in the published rat
genome sequence, simply because it does not cover all
existing allele variations. Alternatively, we might not ﬁnd
our particular L1 sequence because the presently available
sequence ‘draft’ is covering only  90% of the rat genome
(22). Nonetheless, we screened L1base, a database
containing L1Rn elements with intact ORFs (42), by a
BLAST analysis with the L1-3 nucleotide sequence in
order to identify additional potentially functional genomic
L1Rn copies. Of the 377 full-length L1s with intact ORFs
listed in L1base, we identiﬁed eight elements (Figure S4A)
that diﬀer from L1-3-encoded ORF1p and ORF2p only in
 3 residues and  23 residues, respectively (Figure S4B).
Transiently expressed ORF1p appears inthe cytoplasm
withaspeckled pattern and islocalized to thenucleus
If the identiﬁed L1Rn mRNAs, which are coding for both
functional ORFs are actively retrotransposing in RCL
cells, the presence of both functional proteins, ORF1p and
ORF2p, is an essential prerequisite (46). In order to be able
to study the L1Rn-encoded protein machinery, we raised
monoclonal antibodies against proteins encoded by intact
L1 ORFs. To generate antibodies that are able to react
with both major variants of intact ORF1p, we immunized
mice with the recombinant, L1-21-encoded ORF1p
1–143
polypeptide ( 33kDa) lacking the hypervariable
N-terminal region (Figures 5A and S2A). We selected
one hybridoma clone named rG24, which is producing
IgG speciﬁcally recognizing an epitope in the His-
tagged ORF1p
1–143 (Figure 5B) that is expected to be
conserved among the diﬀerent classes of L1Rn ORF1ps.
To conﬁrm the speciﬁcity of this antibody, we transiently
transfected REFs with the L1Rn-ORF1 expression con-
structs pORF1-IRESpuro and pORF1
1–143-IRESpuro
(Figure S6, D and E) and with the empty expression vector
pIRESpuro (BD Biosciences). We chose REF cells because
they do not contain any detectable amounts of RNA
expressed from endogenous genomic full-length L1Rn
elements (Tolstonog and Schumann, data not shown).
Subsequently, transfected cells were tested for speciﬁc
Figure 5. Monoclonal anti-ORF1p
1–143 antibodies (rG24) speciﬁcally recognize ORF1-encoded proteins. (A) Recombinant 33-kDa ORF1p
1–143
was used for the generation of monoclonal antibodies. MW, molecular weight marker. (B) Immunoblot detection of 10ng of puriﬁed His-tagged
ORF1p
1–143 with rG24 (lane 1) and anti-His-tag antibodies (lane 2). (C) Immunoblot analysis examining the speciﬁcity of the generated monoclonal
anti-ORF1p antibody. Sixty microgram whole cell extracts from pORF1p
1–143-IRESpuro (lane 2)- or pIRESpuro-transfected (lane 3) REF cells
were loaded on a 12% SDS–PAA gel. In contrast to the parental empty expression vector pIRESpuro, pORF1p
1–143-IRESpuro is expressing the
N-terminally truncated 33-kDa L1Rn-ORF1 protein, which is detected by the rG24 antibody. As a loading control the membrane was stripped and
incubated with an anti-b-actin antibody; lane 1, 10ng puriﬁed ORF1p
1–143 protein; (D–F) Confocal images of REF cells transfected with ORF1p-
(D, E) and ORF1p
1–143- (F) expressing constructs. ORF1-encoded proteins and vimentin were stained using monoclonal rG24 (green) and
polyclonal anti-vimentin antibodies (red), respectively. The co-localization channel (yellow) was generated using the ImarisColoc module.
Cytoplasmic ORF1p aggregates co-localize with vimentin ﬁlaments partially. Scale bar—10mm.
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immunoblot analysis (Figure 5C) and immunoﬂuorescence
staining with rG24 IgG (Figure 5D–F). The molecular
weight of the polypeptide ( 33kDa) detected with the
rG24 antibody in pORF1
1–143-IRESpuro-transfected,
but not in pIRESpuro-transfected REF cells (Figure 5C)
is consistent with the theoretical mass of the ORF1
1–143
protein expressed in these cells. pORF1-IRESpuro-
transfected cells exhibited predominantly cytoplasmic
staining with the rG24 IgG (Figure 5D and E), indicating
that the antibody is speciﬁcally interacting with the
recombinant ORF1p. The absence of detectable staining
in non-transfected as well as pIRESpuro-transfected REF
cells (data not shown) is consistent with the lack of any
traceable L1 RNA in these cells, indicates that expression
of endogenous L1-encoded ORF1ps is either negligible or
not existing, and supports the speciﬁcity of the rG24
antibody. Concurrently, transfection of REF cells gave us
also the opportunity to study the intracellular localization
of transiently expressed ORF1p and ORF1p
1–143
(Figure 5D–F). Co-localization analyses of deconvoluted
immunoﬂuorescence images of REF cells transiently
transfected with pORF1-IRESpuro, demonstrate that
ORF1p is predominantly cytoplasmic forming large
aggregates with most of them being associated with
vimentin ﬁlaments (Figure 5D). A small subset of
transiently transfected cells (<1%) was characterized by
cytoplasmic as well as nuclear localization of ORF1p
(Figure 5E). These observations are in line with a previous
report demonstrating predominant cytoplasmic aggrega-
tion of transiently expressed L1Hs ORF1p but also
translocation of epitope-tagged L1Hs ORF1p into the
nucleus (53,54). As demonstrated for human ORF1p (10)
and recombinant mouse ORF1p (55), the overexpressed
L1Rn ORF1 protein is probably able to form stable
multimeric complexes, which cannot enter the nucleus (53).
However, an exiguous pool of monomeric ORF1p may
exist in the cytoplasm, at least when overexpressed, which
are small enough to be transported into the nucleus (53).
By contrast, ORF1p
1–143 was distinctly localized to the
nucleus in all transfected cells (Figure 5F), suggesting that
the N-terminal third of ORF1p may either be essential for
the formation of multimers (10), which cannot passively
enter the nucleus, or have a function in cytoplasmic
retention as recently demonstrated for the human L1
ORF1p (54). The nuclear localization of the N-terminally
truncated version of ORF1p could be explained by
the putative bipartite nuclear localization signal
KKEHMETTLDIENQKKR (residues 150–166 in ORF1p
encoded by L1-21) and KRKK (residues 204–207)
predicted in the central third of L1Rn ORF1p
(Figure S2B) by the WoLF PSORT server (43). Our data
are also consistent with the recent identiﬁcation of a
sequence within L1Hs ORF1p that was suggested to be
responsible for the nuclear localization of truncated L1Hs
ORF1p fragments (54).
Multimerization propertiesof L1RnORF1p
Several lines of evidence indicate that L1Rn ORF1ps have
theinherentpropensitytoformoligo/multimers:(i)human,
rabbit and mouse L1 ORF1p have the potential for leucine
zipper- and coiled-coil formation (3,55,56) and in this
respect as well as due to their nucleic acid binding activity
(16) are quite similar to the intermediate ﬁlament (IF)
proteins (57), and (ii) recombinant L1Rn ORF1p tends to
aggregate under non-denaturating conditions forming
ﬁlament-like structures that can be prevented only by the
supplementation of protein solutions with urea or guani-
dinium chloride (Kirilyuk, Tolstonog and Traub, data
not shown).
Applying the computer program MARCOIL which can
predict the coiled-coil domain-characteristic heptad motif
(abcdefg)n (40), we found that 84 amino acid residues in
the conservative central third of L1Rn ORF1p follow a
heptad motif (Figure S2B; I-21p class and I-21a class).
An additional shorter heptad motif was detected in the
N-terminal third of both ORF1p classes, although
the presence of consecutive hydrophobic residues in
positions 76 and 77 of I-21a class ORF1p introduces
some ambiguity (‘stutter’) in assigning residues to the
heptad positions. The in silico predicted polymerization
potential of L1Rn ORF1p was supported by electron
microscopy (Figure S7) and the in situ overlay procedure
(Figure 6A–C). In this experiment, paraformaldehyde
(PFA)-ﬁxed and Triton X-100-permeabilized MEF were
incubated with recombinant L1-21-encoded ORF1p,
whose binding to cellular structures was stabilized by
subsequent ﬁxation with PFA and detected with the rG24
antibody (Figure 6A). Cytoskeletal vimentin ﬁlaments as
the most prominent structure in MEFs were decorated
with anti-vimentin antibody (Figure 6B). Under these
conditions, ORF1p forms ﬁlamentous structures
(Figure 6A) which partially ( 15% pixels) co-aligned
with the vimentin ﬁlament network as demonstrated by
co-localization analysis of the deconvoluted images
(Figure 6C). This result points to a possible direct
interaction between ORF1ps and cytoplasmic IFs or
IF-associated proteins.
In order to conﬁrm the interaction between vimentin
and L1Rn ORF1p, we evaluated the aﬃnity of recombi-
nant ORF1p for several cytoskeletal proteins by far-
western analysis (58). Dot blot overlay assays (Figure 6D)
revealed a high aﬃnity of L1Rn ORF1p for the
cytoplasmic protein vimentin. In contrast, no binding
could be observed for the cytoskeletal proteins a-tubulin
and b-actin.
L1Rn ORF1-and ORF2-encoded proteins are expressed
from endogenous elements inRCL cells
If the rG24 antibody is speciﬁcally recognizing L1Rn
ORF1p and if the ORF1 regions of the identiﬁed full-
length L1 RNA sequences are translated in RCL cells
where L1 retrotransposition takes place, we would expect
to be able to detect members of the two intact ORF1p
classes, I-21p and I-21a, by immunoprecipitation with our
antibody. Indeed, in silver-stained polyacrylamide gels we
could visualize two polypeptides with estimated molecular
weights of  40 and  46kDa (Figure 7A) which corre-
spond to the theoretical molecular masses of the two
classes of ORF1p, I-21pmod-type and I-21a, calculated from
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sequences (Figure 2A). As a next step, we wanted to
determine the distribution of endogenous ORF1p in RCL
cells where the expressed and tagged L1-3 cDNA was
shown to retrotranspose. Confocal microscopy of RCL
cells immunostained with the rG24 IgG localized the vast
majority of ORF1p to the nucleus and only relatively low
or barely detectable amounts to the cytoplasm
(Figure 7B). To conﬁrm nuclear localization of ORF1p,
we next analyzed subcellular fractions of RCL cells for the
presence of L1 ORF1p by immunoblotting with the rG24
antibody (Figure 7D). As expected ORF1-encoded pro-
teins were absent from the cytoplasmic fraction and could
be visualized predominantly in the nuclear fraction. Minor
amounts of ORF1-encoded proteins could also be
detected as faint bands in the cytoskeletal fraction which
is consistent with the weak cytoplasmic immunostaining
of RCL cells (Figure 7B). Endogenous ORF1 proteins
as part of the cytoskeletal fraction are also in support
of the proposed interaction between vimentin and
ORF1p demonstrated in immunoﬂuorescence experiments
(Figure 6A–C) and dot blot overlay assays (Figure 6D).
Molecular weights of the detected proteins correspond
to the ORF1p classes, I-21p and I-21a, and are
consistent with those veriﬁed by immunoprecipitation
(Figure 7A).
In order to generate mouse monoclonal antibodies
speciﬁcally recognizing L1Rn ORF2p, the N-terminal
fragment of the RT domain covering residues Met292 to
480 of ORF2p (Figure 1A, accession no. DQ100473) was
expressed from pET32b-ORF2
M292–480 (Figure S6F) in
bacteria. The resulting ORF2
M292–480–Trx-6xHis fusion
protein was used as antigen for the generation of
monoclonal anti-ORF2p antibodies. We identiﬁed one
hybridoma cell clone (referred to as 2H9) producing IgM
antibodies, which speciﬁcally recognize recombinant
ORF2p
M292–480 in bacterial lysates (data not shown). To
test this antibody for its ability to detect native ORF2p
in situ, we transfected the ORF2p expression construct
pEF6-ORF2 (Figure S6G) into HeLa cells and immuno-
stained them with the 2H9 IgM (Figure 8A). While HeLa
cells that were transfected with the empty vector displayed
Figure 6. L1Rn ORF1p is able to form ﬁlaments that co-align with vimentin ﬁlaments. (A and B) In situ overlay of recombinant L1-21 ORF1p onto
PFA-ﬁxed and Triton X-100-extracted MEFs. Immunoﬂuorescence images of L1Rn ORF1p (A) and vimentin (B) are shown in green and red colors,
respectively. Each panel represents the 3D reconstruction of xy confocal sections. (C) ORF1p and vimentin ﬁlaments co-align partially. The
co-localization channel (yellow) was generated using the ImarisColoc module. Scale bar—10mm. (D) Dot blot overlay assay demonstrating
interaction of ORF1p with vimentin. ORF1p was immobilized onto a nitrocellulose membrane (dots I–IV). Each ORF1p dot contained 2mgo f
protein. After blocking, immobilized ORF1p was overlaid with an excess of soluble vimentin, a-tubulin or b-actin, respectively. Incubation was
carried out for 60min. In order to control for successful immobilization and immunoblotting procedure, 50ng of soluble vimentin, a-tubulin and
b-actin were immobilized on the nitrocellulose membrane in parallel (dots V–VII). Membranes were washed subsequently and submitted to
immunoblot analyses with anti-vimentin, anti-a-tubulin or anti-b-actin antibodies, respectively, due to the schematic shown. In contrast to a-tubulin
and b-actin, only vimentin can be detected with its speciﬁc antibody on the nitrocellulose membrane, after overlaying ORF1p dots with the respective
IF protein (dots I–III). This is indicating that only vimentin is binding to ORF1p.
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may be explained by endogenous human ORF2 expression
(59), transfection with pEF6-ORF2 resulted after only
48h in a much more intense nuclear immunostaining.
Detection of endogenous human L1 ORF2p with the 2H9
IgM could be possible as the antibody is directed against
the RT domain which is highly conserved among human
and murine L1s (Figure S3). To further conﬁrm the
speciﬁcity of the 2H9 antibody, we transiently transfected
REF cells with ORF2p-expressing pEF6-ORF2 and its
empty parental vector pET6V5-His, and tested for speciﬁc
detection of L1Rn ORF2-encoded proteins by immuno-
blot analysis (Figure 8C). A  150-kDa protein was
detected only in extracts from REF cells transfected with
the ORF2p expressing plasmid, but not in those from cells
transfected with the empty vector. This is strongly
suggesting that the anti ORF2p IgM antibody is
speciﬁcally recognizing L1Rn-ORF2 encoded proteins.
Next, we wanted to evaluate whether we were able to
detect ORF2 proteins in RCL cells. This would be
expected, if actively transcribed endogenous L1Rn ele-
ments are mobilized in these cells, as suggested by the L1
retrotransposition reporter assays (Figure 4). Immunoblot
analysis of RCL cell lysates with the 2H9 IgM uncovered
two bands with estimated molecular masses of  150 and
 90kDa (Figure 8D). Detection of a protein with an
approximate molecular mass of 150kDa is consistent with
the translation of L1mlvi2-ORF2p which is encompassing
1275 amino acids and is also encoded by the functional
L1-3 element (accession no. DQ100473, Figure S3). Also,
the weak signal intensity of the  150-kDa band
(Figure 8D and E) would be consistent with a reduction
of the translation rate of ORF2p relative to ORF1p which
was reported to be the consequence of an unconventional
termination/reinitiation mechanism during translation of
human L1 elements (60). In order to test the possibility
that the detected 90-kDa band could be caused by a cross-
reacting protein species not related to L1 which is found in
RCL but not in REF cells, we immunoprecipitated RCL
cell lysates with the 2H9 IgM (Figure 8E) and subjected
the  90-kDa polypeptide to tandem mass spectrometry
Figure 7. Endogenous L1Rn ORF1-encoded proteins are predomi-
nantly localized to the nucleus of RCL cells. (A) Silver staining of
L1Rn ORF1-encoded proteins immunoprecipitated from RCL cell
lysates with RG24 IgG. Molecular weights of the two proteins of  46
and  40kDa correspond to the theoretical masses of L1Rn-ORF1
protein classes I-21a and I-21p, respectively. (B) Confocal images of
RCL cells immunostained with the rG24 antibody (red). (C) Secondary
antibody control. Confocal images were merged with a diﬀerential
interference contrast (DIC) micrograph to show the outlines and nuclei
of cells. Outlines of nuclear envelopes are emphasized in yellow. Scale
bar—10mm. (D) Immunoblot analysis of subcellular fractions of RCL
cells. Three diﬀerent protein fractions (C, cytosolic; N, nuclear; CS,
cytoskeletal matrix proteins) were separated by SDS–PAGE and
blotted onto nitrocellulose. The membrane was incubated consecutively
with anti-ORF1p- antibody (upper panel) and with an antibody
directed against the nucleus-speciﬁc laminB protein (lower panel),
which shows eﬃcient separation of the subcellular fractions.
Figure 8. The monoclonal anti-ORF2p
M292–480 antibody 2H9 detects
endogenous ORF2-encoded proteins. (A and B) Confocal images of
HeLa cells transfected with either ORF2p-expressing pEF6-rORF2
(A) or the parental empty vector pEF6V5-His (B) and stained with the
2H9 IgM (red). (C) Immunoblot analysis examining the speciﬁcity of
the generated monoclonal antiORF2p antibody. Fifty micrograms
of whole cell extract from pEF6-rORF2 (lane 2)- or pEF6V5-His-
transfected (lane 1) REF cells were loaded on a 6% SDS–PAA gel. In
contrast to the parental empty expression vector pEF6V5-His, pEF6-
rORF2 is expressing intact L1Rn ORF2p. As a loading control the
membrane was stripped and incubated with an anti-a1-catenin antibody
(lower panel). (D) Immunoblot analysis of RCL cell extract with
monoclonal 2H9 antibody reveals two bands representing 150- and
90-kDa polypeptides. The 150-kDa band corresponds to the theoretical
molecular mass of L1Rn ORF2p. (E) Silver staining of L1Rn ORF2-
encoded proteins immunoprecipitated from RCL cell lysates with 2H9
IgM. Two polypeptides with apparent molecular masses of 150 and
90kDa were detected and are consistent with the proteins detected by
immunoblot analyses. Scale bar—10mm.
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that the 90-kDa protein recognized by the 2H9 antibody is
the cellular Heat Shock Protein 90 (HSP90) (data not
shown) which is involved in processing and presentation
of cellular peptides (61).
Taken together, we were able to verify the presence of
ORF1- and ORF2-encoded proteins in rat cells by
applying monoclonal antibodies directed against recom-
binant L1Rn-encoded proteins. Molecular weights of the
proteins detected with the anti-ORF1p IgM antibody, and
the identiﬁcation of a  150-kDa polypeptide applying the
anti-ORF2p IgM antibody are consistent with the
presence of functional L1 proteins.
DISCUSSION
Transcription ofbothfunctional and inactive endogenous
full-length L1s coincides with L1retrotransposition in
RCL cells
The recently published genome sequence of R. norvegicus
(22) shows that the rat L1 element is the most successful
member of the mammalian L1 family identiﬁed until now.
Although previous extensive studies of diﬀerent structures
of rat L1s were focusing on 50UTR sequences and ORF1-
coding regions (28), functional L1s whose protein
machinery is responsible for the success of these mobile
elements had not been identiﬁed so far. Therefore, we set
out to identify functional and actively transcribed endo-
genous L1Rn elements, and to generate monoclonal
antibodies to identify L1Rn-encoded proteins. Further-
more, we explored whether functional endogenous L1
elements are mobilized in a given tumor cell line which
could support genome instability generally attributed to
tumor cells.
In RCL cells that were grown under conditions
supporting transcriptional activation of L1Rn (30,31,62),
we detected signiﬁcant amounts of L1-speciﬁc transcrip-
tional products of three diﬀerent sizes (Figure 1B). We
were able to generate 10 L1 cDNAs from RNA isolated
from UV-irradiated RCL cells, each covering nearly
full-length L1 sequences. The fact that we isolated
almost full-length cDNAs from RCL cells is suggesting
that they are derived from the putative  7-kb full-length
transcripts and/or the putative  8.3-kb read-through
products. Six isolated L1Rn cDNAs, including the
functional L1-3 sequence, are derived from the phylo-
genetically youngest family of L1Rn elements, the
I-21pmod-type, and only four originate from the older
I-21a class (25,29). While each of the cDNAs had coding
capacity for intact ORF1ps, only two of them also
included non-interrupted ORF2 coding regions, and
therefore had the potential to represent RC-L1s.
Applying a retrotransposition reporter assay in HeLa as
well as in RCL cells, we tested the latter two cDNAs for
their potential to retrotranspose. We demonstrated that
only the L1-3 cDNA is functional and the transposition
rate in HeLa cells amounted to 30% relative to the highly
active human L1 element, L1RP. De novo insertions carry
the hallmarks of human L1 retrotransposition initiated by
TPRT (19). We further show that the tagged L1-3 cDNA
can retrotranspose in the RCL tumor cell line the
endogenous L1-3 element was originally expressed in
and from which its RNA was isolated. Therefore, we
conclude that the untagged, endogenously expressed L1-3
RNA is also retrotransposing in RCL cells. This conclu-
sion is supported by a previous publication presenting
evidence for transcriptional activation of endogenous
L1Rn elements in RCL cells and subsequent ampliﬁcation
of genomic L1 sequences  24h later (30). Activation of
endogenous L1 expression is also observed in chronic
myeloid leukemia (CML) cells isolated from CML patients
(63), and it was shown to be caused by hypomethylation of
L1 promoter sequences. It was suggested that such a
reactivation of retroelements might contribute to genomic
instability in cancer (64). Furthermore, it was hypothesized
that ongoing L1 retrotransposition in CML cell lines might
be an explanation for the observation that the transition of
CML from the chronic phase to the blast crisis is
characterized by the accumulation of molecular and
chromosomal abnormalities (65).
Translationand subcellular localization of ORF1p
Similar to L1Hs, the L1Rn transcript is unusual because a
60-bp intergenic spacer containing two in-frame stop
codons separates ORF1 and ORF2 (Figure 2B). It is likely
that L1Rn-encoded ORF1p and ORF2p are translated
from one full-length, bicistronic L1 mRNA by an
unconventional termination/reinitiation mechanism
(45,60,66–69). Also, the fact that our rG24 antibody
reactive to native L1Rn ORF1p has only identiﬁed  40-
and  46-kDa products argues against the synthesis of an
ORF1p-ORF2p fusion protein (3). Consistently, immu-
noblot analyses of RCL cell extracts with the anti-ORF2p
antibody led to the detection of a  150kDa protein in
RCL cells (Figure 8D). This again is in accordance with
the detection of an L1 ORF2 protein with a similar
molecular weight in human cells (59).
Our experiments indicate that both L1Rn ORF1p
classes, I-21a and I-21p, are present in RCL cells
(Figure 7A, B and D) The results are suggesting that
there is no obvious bias in expression activity of any of the
two classes, and that there is a highly heterogeneous group
of ORF1ps expressed in these cells. Because 9 out of 10
isolated close-to-full-length cDNAs are retrotransposi-
tion-incompetent but are coding for intact ORF1ps, it can
be concluded that the vast majority of the detected cellular
ORF1ps is not part of functional RNP complexes. The
heterogeneous pool of ORF1p visualized in the nuclei of
RCL cells could also include defective proteins, which are
encoded by mutated L1 ORF1 copies. Also, a fraction
of the detected  40-kDa ORF1ps may be the result of
expression of copies of the non-autonomous HAL1
element that is derived from L1 by deletion of its ORF2
(70). There are about 7500 HAL1 copies in the rat
genome, and it was concluded that the currently identiﬁed
HAL1-like elements (RNHAL1) still propagate (22).
RNHAL1 contains only an ORF1, and the 50 2600 bases
are 98% identical to the L1 currently active in rat (29).
The repeated origin and high copy number of HAL1s
suggest that the ORF1 product, which binds strongly to its
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target for L1-mediated reverse transcription. Taken
together, the majority of these heterogeneous, endogenous
ORF1p may not be able to be part of functional L1 RNPs,
because of the absence of an intact ORF2 protein, or
because they are not able to multimerize or interact with
their full-length RNA due to mutations. These monomeric
ORF1ps may be small enough to be transported into the
nucleus and cause the predominant nuclear staining of
RCL cells observed in Figure 7B. Accumulation of both
the vast majority of endogenous ORF1p and a fraction
of transiently expressed ORF1p in the nuclei of RCL and
few REF cells (Figures 7B and 5E), respectively, could
be explained by two predicted NLS in the conserved
C-terminal two-thirds of both L1Rn-ORF1p classes
(Figures 2A and S2B). The presence of an NLS in
ORF1p is supported by the exclusive nuclear localization
of the transiently expressed, N-terminally truncated
ORF1p
1–143 in REF cells (Figure 5F). As, by contrast,
transiently expressed ORF1p was found predominantly in
the cytoplasm in an aggregated form (Figure 5D and E),
the N-terminal third of ORF1p may either be essential
for the formation of multimers (10) which cannot be
transported into the nucleus, or have a function in
cytoplasmic retention as recently demonstrated for the
human L1 ORF1p (54).
Although endogenous ORF1p patterns in mouse
and humans were described to be predominantly cyto-
plasmic (10,12), more recent publications are reporting
that L1 ORF1p is also migrating into the nucleus:
(i) Transiently expressed functional human ORF1p
was detected mainly in the cytoplasm and in
nucleolar sites in human osteosarcoma and MCF-7 cells
(53,72). (ii) Immunohistochemical analyses revealed both
cytoplasmic and nuclear localization of rat ORF1p in
cardiomyocytes (34); (iii) Tagged human L1 ORF1p
was visualized in the nucleus of human 143 Btk- and
293T cells (54).
Also, the ORF1-encoded Gag protein of TART, a
LINE-like non-LTR retrotransposon from Drosophila,i s
found predominantly in the nucleus where it has a role in
telomeric localization of TART (73). Although the precise
function of ORF1p in L1 retrotransposition remains
unclear, the nucleic acid chaperone activity of ORF1p
proposed to contribute to reverse transcription by TPRT
(56) would require the presence of functional ORF1p in
the nucleus.
The interaction between ORF1p and vimentin observed
under in vitro conditions raises the possibility that
cytoskeletal proteins, such as IF proteins, might be
important for the intracellular localization of ORF1p
(Figure 6). The localization of RNA encoded by the
LINE-like retrotransposon Doc in the region of the
cytoskeleton of Drosophila oocytes (74) would be con-
sistent with a role of IFs in intracellular localization of
retrotransposon RNPs. Two possible roles of an interac-
tion of ORF1p with intermediate ﬁlaments could be
envisioned:
One of the steps of the L1 retrotransposition cycle that
could be aﬀected by this interaction is the transport
of cytoplasmic RNP complex particles to the nucleus.
Since intermediate ﬁlaments directly connect nuclear and
plasma membranes (75), they could serve as a guide to
direct RNPs toward the nucleus. ORF1p, as a major part
of the L1 RNP and because of its aﬃnity for vimentin,
could consequently serve as an anchor molecule and allow
the two-dimensional movement of RNPs along IFs
through the cytoplasm to the nuclear membrane. Such a
guided movement of RNPs would be signiﬁcantly more
eﬃcient than undirected diﬀusion. A similar role in the
guided movement of viral particles from the cytoplasm to
the nucleus was proposed for the recently reported
interaction between human immunodeﬁciency virus type
1 (HIV-1) Vif protein and vimentin (76). Theiler’s murine
encephalomyelitis (TMEV) capsid protein was also shown
to interact with vimentin (77) but the function of this
interaction is unknown.
Alternatively, vimentin may interact with L1 ORF1p as
one component of stress granules (54). This would suggest
a mechanism whereby the host cell may attenuate
the potential mutagenic eﬀects of retrotransposition by
sequestering L1 RNPs and possibly targeting them for
degradation (54). This hypothesis is supported by the
ﬁnding that RNP particles of variable composition (stress
granules) are associated with vimentin in Ptk1 and HeLa
cells (78).
Unfortunately, ORF2p localization studies in RCL cells
cannot be performed with our monoclonal 2H9 antibody
raised against recombinant L1Rn ORF2p, because mass
spectrometry revealed that this antibody is not only
recognizing the L1Rn ORF2-encoded 150-kDa protein
but is also cross-reacting with the cellular HSP90 protein.
Nevertheless, this antibody is applicable for the study of
recombinant L1Rn ORF2p transiently expressed in
transfected cells (Figure 8C). In silico analyses of the
L1-3-encoded ORF2p sequence on the PredictNLS server
(44) revealed that the conservative amino acid sequence
LRDKDR (residues 48–53, accession no. AAY88216)
which is localized within the EN domain, is a putative
NLS. Its functionality in the context of the EN domain is
supported by the nuclear localization of transiently
expressed full-length L1Rn ORF2p in HeLa cells
(Figure 8A). The observation that transiently expressed
full-length L1Hs ORF2p is mainly accumulated in the
cytoplasm of HeLa cells (59) and 143B osteosarcoma
cells (53) could be explained by diﬀerences between the
putative NLS sequences of L1Rn-EN (LRDKDR) and the
respective corresponding region in L1Hs-EN (LTDKDT)
(Figure S3). Based on analyses on the PredictNLS server,
the latter sequence motif is not consistent with a putative
NLS function.
Applications
The functional L1Rn element L1-3 has the potential to
serve as a tool in transgenic research. In recent years,
transgenic rats were increasingly favored as model
organisms to study cardiovascular diseases and brain
physiology. Also, the laboratory rat is the principle model
in the initial stages of drug development because their
organ sizes allows more detailed investigations, which are
problematic in mice (79). In transgenic rats, a tagged
662 Nucleic Acids Research, 2008, Vol. 36, No. 2functional L1Rn element that is under control of a tissue-
speciﬁc promoter will be useful as insertional mutagen or
as a gene-trap tool helping to dissect genetic mechanisms
of pathologic processes. Furthermore, the ORF1p-speciﬁc
monoclonal antibody described in this work will enable
cell-biological studies on L1 ORF1p with broad applica-
tion to rat tumor models and will help expand our
knowledge about L1 biology and the role of L1s in disease
development and tumorigenesis.
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